292 related articles for article (PubMed ID: 16411146)
21. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
23. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
[TBL] [Abstract][Full Text] [Related]
24. Long-term impact of initial surgical and medical therapy on young patients with papillary thyroid cancer and bilateral cervical metastases.
Ji QH; Zhang L; Zhu YX; Huang CP
Chin Med J (Engl); 2008 Jan; 121(1):63-6. PubMed ID: 18208668
[TBL] [Abstract][Full Text] [Related]
25. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
26. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
27. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and molecular disease prognostication for papillary thyroid cancer.
Miccoli P; Miccoli M; Antonelli A; Minuto MN
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1261-75. PubMed ID: 19761430
[TBL] [Abstract][Full Text] [Related]
29. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma.
Uruno T; Miyauchi A; Shimizu K; Nakano K; Takamura Y; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K
Surg Today; 2004; 34(11):891-5. PubMed ID: 15526121
[TBL] [Abstract][Full Text] [Related]
30. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.
Soares J; Limbert E; Sobrinho-Simões M
Pathol Res Pract; 1989 Aug; 185(2):200-6. PubMed ID: 2798220
[TBL] [Abstract][Full Text] [Related]
31. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
32. The role of radioactive iodine therapy in young patients with papillary thyroid cancer.
Kuo SF; Chao TC; Chang HY; Hsueh C; Chang YC; Yang CH; Lin JD
Clin Nucl Med; 2009 Jan; 34(1):4-6. PubMed ID: 19092372
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
[TBL] [Abstract][Full Text] [Related]
34. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
35. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.
Lin HW; Bhattacharyya N
Laryngoscope; 2010 Apr; 120(4):712-6. PubMed ID: 20205241
[TBL] [Abstract][Full Text] [Related]
36. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
37. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
Thompson LD; Wieneke JA; Heffess CS
Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
[TBL] [Abstract][Full Text] [Related]
38. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
[TBL] [Abstract][Full Text] [Related]
39. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
40. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]